PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 4, 2026Synthetic biology and engineering0 citationsOpen Access

Synthetic Biology–Driven Innovation in the Production of Cosmetic Ingredients: From Natural Mimicry to Precision Creation

YJYi JinhangZMZhang MengxiHFHu Fangying

Key Points

  • The aim is to explore the evolution of cosmetic ingredients through synthetic biology techniques, focusing on efficiency and customization.
  • Examined advances in synthetic biology and biomanufacturing processes
  • Identified trends in enzyme engineering and metabolic control
  • Assessed the potential of star molecules like ergothioneine and spermidine
  • Synthetic biology technologies improve production efficiency and reduce costs
  • Customization possible through dynamic metabolic control and enzyme engineering
  • AI-driven R&D can enhance the development of innovative cosmetic ingredients

Abstract

The cosmetics industry is undergoing a historic transition from natural extraction to precision biomanufacturing. Amino acid derivatives, as a kind of core functional cosmetic ingredient, have witnessed synthetic biology–based production technologies overcome traditional bottlenecks in efficiency and cost. In this Perspective, grounded in recent advances in the construction of amino acid derivative cell factories, we propose the core trends for the future development of cosmetic ingredients: enzyme engineering, dynamic metabolic control, and irrational strategies are converging to enable both functional customization and production intelligence. Star molecules such as ergothioneine, spermidine, and bioactive peptides are poised to redefine the boundaries of anti-aging efficacy, while AI-driven R&D paradigms offer broad prospects but must still overcome cost, regulatory, and consumer perception barriers. We emphasize that only by establishing an integrated “efficient synthesis–precise delivery–validated activity” end-to-end chain can cosmetic ingredients move from laboratory to market, achieving an industrial leap from chemical addition to biological empowerment.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Jinhang et al. (2026) studied this question.

synapsesocial.com/papers/69a7ccf7d48f933b5eed8ec5https://doi.org/10.70322/sbe.2026.10003
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Metabolic reprogramming and biosensor-assisted mutagenesis screening for high-level production of L-arginine in Escherichia coli2023 · 78 citations
  2. 2Current Advances of Nanocarrier Technology-Based Active Cosmetic Ingredients for Beauty Applications2021 · 94 citations
  3. 3Heterologous gshF gene expression in various vector systems in Escherichia coli for enhanced glutathione production2015 · 32 citations
  4. 4Spermidine in health and disease2018 · 1,146 citations
  5. 5Toward more efficient ergothioneine production using the fungal ergothioneine biosynthetic pathway2022 · 51 citations